GLREHIGH SIGNALFINANCIAL10-K

GLRE achieved substantial deleveraging by reducing total debt 92% while significantly strengthening its cash position and profitability.

The dramatic debt reduction from $60.7M to $4.7M, combined with a 73% increase in cash to $111.8M, represents a major balance sheet transformation that substantially improves financial flexibility. The company's reinsurance business momentum is evident with 10.7% growth in gross premiums written, while operating cash flow generation more than doubled, demonstrating strong underlying business performance.

Comparing 2026-03-09 vs 2025-03-10View on EDGAR →
FINANCIAL ANALYSIS

GLRE delivered exceptionally strong financial results with net income growing substantially while achieving near-complete debt elimination and a significant cash build to $111.8M. Operating cash flow generation more than doubled to $210.2M, demonstrating robust business performance that supported both the debt paydown and increased shareholder returns through higher buybacks. The combination of deleveraging, improved profitability, and strong cash generation signals a company in excellent financial health with enhanced strategic flexibility.

FINANCIAL STATEMENT CHANGES
Total Debt
Balance Sheet
-92.2%
$60.7M$4.7M

Debt reduced 92.2% — deleveraging strengthens balance sheet and reduces financial risk.

Operating Cash Flow
Cash Flow
+88.5%
$111.5M$210.2M

Operating cash flow surged 88.5% — exceptional cash generation, highest quality earnings signal.

Net Income
P&L
+74.8%
$42.8M$74.8M

Net income grew 74.8% — bottom-line growth signals improving overall business health.

Cash & Equivalents
Balance Sheet
+72.8%
$64.7M$111.8M

Cash position surged 72.8% — strong cash generation or capital raise providing significant financial cushion.

Share Buybacks
Cash Flow
+31.2%
$7.5M$9.8M

Share repurchases increased 31.2% — management returning capital, signals confidence in intrinsic value.

Stockholders Equity
Balance Sheet
+11.3%
$635.9M$708.0M

Equity base grew 11.3% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2026-03-09
PRIOR — 2025-03-10
ADDED
At March 9, 2026, there were 33,983,603 ordinary shares outstanding, $0.10 par value per share, of the registrant.
Summary of Risk Factors The following is a summary of the principal risks that we believe could adversely affect our business, operations, and financial results.
Investments in privately held early-stage companies ( private equities ) involve significant risks, and are highly illiquid.
Refer to Part II, Item 7, Management Discussion and Analysis - Key Financial Measures and Non-GAAP Measures for further details.
Further, since 2018, our Innovations business unit has supported innovative, technology-driven insurance partners, both in the form of seed capital and reinsurance capacity.
+7 more — sign up free →
REMOVED
At March 10, 2025, there were 34,564,176 ordinary shares outstanding, $0.10 par value per share, of the registrant.
We believe that these factors include, but are not limited to: any suspension or revocation of any of our licenses; losses from catastrophes and other major events; a downgrade or withdrawal of our A.M.
Investments in privately held early-stage companies involve significant risks, and are highly illiquid.
Refer to Part II, Item 7, Management Discussion and Analysis - Key Financial Measures and N on-GAAP Measures for further details.
Further, since 2018, we have operated an Innovations business unit to support innovative, technology-driven insurance partners, both in the form of seed capital and reinsurance capacity.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →